Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CRBN | Q96SW2 | 19/20 | 0.49 |
| ▸ | DDB1 | Q16531 | 10/20 | 0.47 |
| ▸ | IKZF3 | Q9UKT9 | 1/20 | 0.40 |
| ▸ | BRD4 | O60885 | 2/20 | 0.37 |
| ▸ | RIPK1 | Q13546 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31055478 | 1.00 | CRBN (0.49) | CRBNDDB1IKZF3BRD4RIPK1 | |
| SCHEMBL24671245 | 0.92 | CRBN (0.46) | CRBNDDB1IKZF3 | |
| SCHEMBL30720114 | 0.88 | CRBN (0.63) | CRBNDDB1 | |
| SCHEMBL27238864 | 0.88 | CRBN (0.63) | CRBNDDB1 | |
| SCHEMBL27260521 | 0.88 | CRBN (0.63) | CRBNDDB1 | |
| SCHEMBL29579057 | 0.87 | CRBN (0.58) | CRBNDDB1 | |
| SCHEMBL24481327 | 0.87 | CRBN (0.58) | CRBNDDB1 | |
| SCHEMBL24671188 | 0.86 | CRBN (0.55) | CRBNDDB1IKZF3BRD4 | |
| SCHEMBL30066382 | 0.86 | CRBN (0.55) | CRBNDDB1IKZF3BRD4 | |
| SCHEMBL24421608 | 0.85 | CRBN (0.56) | CRBNDDB1IKZF3BRD4RIPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117693502-A | Compounds for inhibiting or degrading ITK, compositions comprising the same, methods of making the same, and methods of using the same | 纽力克斯治疗公司 | 2024-03-12 | — | — | CN | disclosed |
| WO-2022235715-A1 | COMPOUNDS FOR INHIBITING OR DEGRADING ITK, COMPOSITIONS, COMPRISING THE SAME METHODS OF THEIR MAKING AND METHODS OF THEIR USE | NURIX THERAPEUTICS, INC. (US) | 2022-11-10 | — | — | WO | disclosed |